| 000 | 01769 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250514193300.0 | ||
| 264 | 0 | _c20060317 | |
| 008 | 200603s 0 0 eng d | ||
| 022 | _a0954-6928 | ||
| 024 | 7 |
_a10.1097/01.mca.0000135221.32523.a1 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aKural, Birgül Vanizor | |
| 245 | 0 | 0 |
_aThe effects of lipid-lowering therapy on paraoxonase activities and their relationships with the oxidant-antioxidant system in patients with dyslipidemia. _h[electronic resource] |
| 260 |
_bCoronary artery disease _cAug 2004 |
||
| 300 |
_a277-83 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAnticholesteremic Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aAntioxidants _xmetabolism |
| 650 | 0 | 4 |
_aAryldialkylphosphatase _xmetabolism |
| 650 | 0 | 4 | _aAtorvastatin |
| 650 | 0 | 4 |
_aBiomarkers _xblood |
| 650 | 0 | 4 |
_aCholesterol, HDL _xmetabolism |
| 650 | 0 | 4 |
_aCholesterol, LDL _xmetabolism |
| 650 | 0 | 4 |
_aDyslipidemias _xdrug therapy |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aHeptanoic Acids _xtherapeutic use |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHydroxymethylglutaryl-CoA Reductase Inhibitors _xtherapeutic use |
| 650 | 0 | 4 |
_aLipoproteins, LDL _xmetabolism |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aPyrroles _xtherapeutic use |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aOrem, Cihan | |
| 700 | 1 | _aUydu, Hüseyin A | |
| 700 | 1 | _aAlver, Ahmet | |
| 700 | 1 | _aOrem, Asim | |
| 773 | 0 |
_tCoronary artery disease _gvol. 15 _gno. 5 _gp. 277-83 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1097/01.mca.0000135221.32523.a1 _zAvailable from publisher's website |
| 999 |
_c14942455 _d14942455 |
||